Characterization of gag gene of plasma HIV type 1 in combination therapy-treated AIDS patients with high viral load and stable CD4+ T cell counts

AIDS Research and Human Retroviruses

Volumn 19, Issue 1, 2003, Pages 73-76

  Saurya, Shreesh ^a   Lichtenstein, Zelman ^b   Karpas, Abraham ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b St Wolfgangs Platz   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DELAVIRDINE; DIDANOSINE; GAG PROTEIN; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; SYREA; UNCLASSIFIED DRUG; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; HUMAN; LYMPHOCYTE COUNT; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA EXTRACTION; VIRUS CAPSID; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD;

AMINO ACID SEQUENCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; GENES, GAG; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 0037252647     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220360473998     Document Type: Article

References (14)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Mocroft A, Vella S, Benfield TL, et al.: Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-1730.
3. Kaufmann D, Pantaleo G, Sudre P, and Telenti A: CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet 1998;351:723-724.
4. + T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis 2000;181:946-953.
5. Huang Y, Zhang L, and Ho DD: Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 1998;240:36-49.
6. Staden R, Beal KF, and Bonfield JK: The Staden package, 1998. Methods Mol Biol 2000;132:115-130.
7. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL_X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
8. Rice PLI and Bleasby A: EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet 2000;16:276-277.
9. Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, and Sundquist WI: Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol 1994;244:198-223.
10. Wang CT and Barklis E: Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J Virol 1993;67:4264-4273.
11. Gottlinger HG, Dorfman T, Sodroski JG, and Haseltine WA: Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 1991;88:3195-3199.
12. Ott DE, Chertova EN, Busch LK, Coren LV, Gagliardi TD, and Johnson DG: Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein. J Virol 1999;73:19-28.
13. + T-cell counts. AIDS Res Hum Retroviruses. 2002;18:983-987.
14. + T cells on combination therapy. AIDS Res Hum Retroviruses. 2002;18:1151-1155.